Ethan V. Abel

PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression

Kim H.T. Paraiso, Yun Xiang, Vito W. Rebecca et al. · Cancer Research · 2011 · 544 citations · Full text

Cancer Research, Cell Regulation, Medicine +15

SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells

Marta Herreros‐Villanueva, Zhang Js, Alexander Köenig et al. · Oncogenesis · 2013 · 334 citations · Full text

Cell-like Features, Cancer Stem Cell, Pancreatic Cancer Cells +17

Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Edward Kim, Vaibhav Sahai, Ethan V. Abel et al. · Clinical Cancer Research · 2014 · 302 citations · Full text

Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3

Ethan V. Abel, Kevin J. Basile, Curtis H. Kugel et al. · Journal of Clinical Investigation · 2013 · 236 citations · Full text

Enhanced Erbb3, Medicine, Melanoma +11

GM-CSF Mediates Mesenchymal–Epithelial Cross-talk in Pancreatic Cancer

Meghna Waghray, Malica Yalamanchili, Michele Dziubinski et al. · Cancer Discovery · 2016 · 205 citations · Full text